Study to Evaluate the Performance and Safety of the Medical Device Argogen

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 21, 2023

Primary Completion Date

December 6, 2023

Study Completion Date

December 6, 2023

Conditions
Burn WoundPressure Ulcers Stage IIPressure Ulcers Stage III
Interventions
DEVICE

Argogen (silver zeolite powder)

The medical device will be self-administered by each patient twice daily without interruption for the duration of the study (4 weeks) or until complete healing. Application is carried out by spraying at short intervals, lightly pressing the dispenser button and directing the spray onto the area to be treated.

Trial Locations (2)

200061

MC Medica SRL, Craiova

450117

SC Salvosan Ciobanca SRL, Zalău

All Listed Sponsors
collaborator

Opera CRO, a TIGERMED Group Company

OTHER

lead

Signorini Medicale S.r.l.

INDUSTRY